Visit the CAS COVID-19 Resources page to download a dataset of antiviral candidate compounds, a protein target thesaurus, and more.
Solve Scientific Information Challenges
Whether you are trying to advance your research, repurpose existing technology or make strategic investment decisions, CAS can help you get there faster while minimizing risk.
CAS is a global organization of expert scientists, technologists, and business leaders with a successful and extended history of delivering scientific information opportunities.
From our market-leading products, like SciFindern and STN®, to solutions tailored to your specific needs, we are ready to partner with you.
CAS can help
Accelerate Innovation
- Generate new ideas
- Expand your pipeline
- Get to market faster
- Enhance productivity
Manage Information
- Harness the power of big data
- Provide quality content & tools
- Integrate & manage resources
- Enable accessibility
Protect Intellectual Property
- Maximize the value of your portfolio
- Understand the landscape
- Avoid surprises
- Align strategy with opportunity
CAS Products
CAS offers a wide range of solutions designed to meet the needs of research, patent, regulatory, and business professionals in every phase of the innovation process.
CAS Services
With over 100 years’ experience, no one knows more about working with scientific information than CAS. Leverage our expertise to customize solutions for your organization’s unique information challenges.
Being able to rapidly search for important chemical information while an idea is fresh in your mind is almost priceless. CAS databases streamline the investigative process—allowing you to take an idea and rapidly find the important and necessary information before you forget about the idea or it loses its excitement. That really is invaluable.
Dr. Robert H. GrubbsNobel LaureateVictor and Elizabeth Atkins Professor of Chemistry, California Institute of Technology
Contact CAS
Let us know how we can best serve you.
Resources
Press Releases
CAS announces signing of multi-year enterprise agreement with P&G
CAS announces signing of multi-year enterprise agreement with P&G that expands long-term partnership to support CPG leader’s commitment to disruptive innovation. Global access to leading scientific information solutions portfolio informs business strategy and fuels efficient R&D to deliver superior consumer product performance.
Read more
Read more
Articles
Potential therapeutic agents and associated bioassay data for COVID-19 and related human coronavirus infections
To support ongoing research and development of COVID-19 therapeutics, this report provides an overview of protein targets and corresponding potential drug candidates with bioassay and structure-activity relationship data found in the scientific and patent literature for COVID-19 or related virus infections.
Read more
Articles
Protecting and Commercializing the Promise of RNAi
In this article from The Patent Lawyer Magazine, Anne Marie Clark, Senior Search Analyst for CAS, discusses how to avoid patent pitfalls as the market for RNAi-derived therapeutics grows.
Read more